Daily Stock Analysis, ACIU, AC Immune Ltd, priceseries

AC Immune Ltd. Daily Stock Analysis
Stock Information
Open
10.00
Close
10.24
High
10.49
Low
9.60
Previous Close
10.57
Daily Price Gain
-0.33
YTD High
14.06
YTD High Date
Jan 9, 2017
YTD Low
6.03
YTD Low Date
Aug 10, 2017
YTD Price Change
-2.77
YTD Gain
-21.29%
52 Week High
19.97
52 Week High Date
Sep 28, 2016
52 Week Low
6.03
52 Week Low Date
Aug 10, 2017
52 Week Price Change
-5.42
52 Week Gain
-34.61%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Aug 30. 2017
7.63
Sep 22. 2017
9.94
15 Trading Days
30.29%
Link
Company Information
Stock Symbol
ACIU
Exchange
NasdaqGM
Company URL
http://www.acimmune.com
Company Phone
-
CEO
Andrea Pfeifer
Headquarters
-
Business Address
-
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001651625
About

AC Immune SA is a clinical stage biopharmaceutical company, which engages in leveraging two proprietary technology platforms to discover, design and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. It's products includes: crenezumab, a humanized, monoclonal, conformation-specific anti-Abeta antibody that developed using the SupraAntigen™ platform. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, and Andrea Pfeifer on February 13, 2003 and is headquartered in Lausanne, Switzerland.

Description

AC Immune SA is a biopharmaceutical company. It is engaged in leveraging its two proprietary technology platforms to discover, design and develop novel, proprietary medicines for treatment of neurodegenerative diseases.